Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

September 30, 2004

Study Completion Date

January 31, 2006

Conditions
Lung Cancer
Interventions
DRUG

6-hydroxymethylacylfulvene

11mg/sq m IV infusion over 5 min q day for 5 days each 28 day cycle

Trial Locations (48)

10021

Memorial Sloan-Kettering Cancer Center, New York

New York Presbyterian Hospital - Cornell Campus, New York

10029

Mount Sinai Medical Center, NY, New York

11030

CCOP - North Shore University Hospital, Manhasset

North Shore University Hospital, Manhasset

13210

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse

State University of New York - Upstate Medical University, Syracuse

Veterans Affairs Medical Center - Syracuse, Syracuse

14215

Veterans Affairs Medical Center - Buffalo, Buffalo

19899

CCOP - Christiana Care Health Services, Wilmington

20007

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington D.C.

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

23249

Veterans Affairs Medical Center - Richmond, Richmond

27705

Veterans Affairs Medical Center - Durham, Durham

27710

Duke Comprehensive Cancer Center, Durham

33140

CCOP - Mount Sinai Medical Center, Miami Beach

35233

Veterans Affairs Medical Center - Birmingham, Birmingham

38104

Veterans Affairs Medical Center - Memphis, Memphis

38163

University of Tennessee, Memphis Cancer Center, Memphis

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

52242

University of Iowa Hospitals and Clinics, Iowa City

55417

Veterans Affairs Medical Center - Minneapolis, Minneapolis

60612

University of Illinois at Chicago Health Sciences Center, Chicago

Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago

60637

University of Chicago Cancer Research Center, Chicago

63110

Barnes-Jewish Hospital, St Louis

65201

Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia

65203

Ellis Fischel Cancer Center - Columbia, Columbia

68105

Veterans Affairs Medical Center - Omaha, Omaha

89106

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas

94121

Veterans Affairs Medical Center - San Francisco, San Francisco

92093-0658

University of California San Diego Cancer Center, La Jolla

94115-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

20307-5000

Walter Reed Army Medical Center, Washington D.C.

04330

Veterans Affairs Medical Center - Togus, Togus

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

01655

University of Massachusetts Memorial Medical Center, Worcester

68198-3330

University of Nebraska Medical Center, Omaha

03756

Norris Cotton Cancer Center, Lebanon

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27104-4241

CCOP - Southeast Cancer Control Consortium, Winston-Salem

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

02903

Rhode Island Hospital, Providence

29425-0721

Medical University of South Carolina, Charleston

05009

Veterans Affairs Medical Center - White River Junction, White River Junction

23298-0037

MBCCOP - Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003666 - Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter